What are the risk factors for acute bacterial rhinosinusitis in children, particularly those with a history of allergies, asthma, or previous respiratory infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Risk Factors for Acute Bacterial Rhinosinusitis in Children

The primary risk factors for developing acute bacterial rhinosinusitis (ABRS) in children are recent viral upper respiratory infection (the most common predisposing factor), allergic rhinitis, attendance at child care, recent antibiotic use within 30 days, and age younger than 2 years. 1

Infectious and Environmental Risk Factors

Viral Upper Respiratory Infection

  • Viral URI is the single most important predisposing factor for ABRS in children, occurring when inflammation of the nasal and sinus mucosal lining from viral infection creates conditions for bacterial superinfection. 1
  • Approximately 8% of viral upper respiratory infections are complicated by acute viral sinusitis, which can then progress to bacterial sinusitis. 1
  • The typical progression involves initial viral infection followed by bacterial superinfection when symptoms persist beyond 10 days, worsen after initial improvement, or present with severe onset. 1

Child Care Attendance

  • Children attending day care have significantly increased risk for ABRS due to higher exposure to respiratory pathogens and increased frequency of viral URIs. 1
  • Day care attendance is specifically identified as a risk factor for antibiotic-resistant organisms, particularly β-lactamase-positive Haemophilus influenzae and penicillin-nonsusceptible Streptococcus pneumoniae. 1

Recent Antibiotic Exposure

  • Receipt of antimicrobial treatment within the previous 30 days substantially increases risk for both ABRS development and antibiotic-resistant bacterial pathogens. 1
  • This risk factor is critical when selecting initial antibiotic therapy, as it predicts organisms likely resistant to amoxicillin. 1

Age-Related Risk Factors

  • Children younger than 2 years have elevated risk for both ABRS and antibiotic-resistant organisms. 1
  • This age group experiences 6-8 URIs per year on average, creating multiple opportunities for bacterial superinfection. 2
  • Infants under 6 months can develop severe complications from nasal congestion due to obligate nasal breathing. 2

Allergic and Atopic Conditions

Allergic Rhinitis

  • Allergic rhinitis is the second most common predisposing factor for ABRS after viral infection, causing mucosal inflammation and impaired sinus drainage. 1
  • Children with documented allergic rhinitis should receive intranasal steroids and nonsedating antihistamines to reduce ABRS risk. 1
  • However, allergic rhinitis is uncommon as a cause of chronic nasal symptoms in children under 2 years of age. 2

Asthma and Atopic Diathesis

  • Children with asthma and other atopic conditions (eczema, atopic dermatitis) may have increased susceptibility to ABRS, though this is primarily through the mechanism of allergic rhinitis rather than asthma itself. 3
  • The presence of atopic stigmata (nasal crease, allergic shiners, eczematous changes) should be documented when evaluating children with recurrent respiratory symptoms. 3

Underlying Medical Conditions

Recurrent Acute Bacterial Sinusitis (RABS)

Children with ≥4 episodes of ABRS per year meeting strict diagnostic criteria warrant evaluation for the following underlying conditions: 1

  • Immunodeficiency: Quantitative immunoglobulin A and immunoglobulin G deficiency 1
  • Cystic fibrosis: Should be considered in children with recurrent sinopulmonary infections 1
  • Gastroesophageal reflux disease: Can contribute to chronic inflammation and recurrent infections 1
  • Ciliary dysfunction: Dysmotile cilia syndrome impairs normal mucociliary clearance 1

Anatomical Abnormalities

  • Nasal airway obstruction from various causes increases ABRS risk. 1
  • Specific anatomical factors include: septal deviation, nasal polyps, concha bullosa (pneumatization of middle turbinate), atypical ethmoid cells with compromised drainage, lateralized middle turbinate, and intrinsic ostiomeatal anomalies. 1
  • Adenoidal hypertrophy is the most common acquired anatomic cause of nasal obstruction in young children and can predispose to ABRS. 2
  • Genetic or acquired craniofacial abnormalities require evaluation with contrast-enhanced CT, MRI, or endoscopy. 1

Odontogenic Infections

  • Dental infections can lead to maxillary sinusitis in children, though this is less common than other predisposing factors. 1

Risk Stratification for Antibiotic Resistance

When selecting initial antibiotic therapy, the following combination of risk factors predicts organisms likely resistant to standard-dose amoxicillin: 1

  • Age younger than 2 years
  • Day care attendance
  • Antibiotic use within previous 30 days
  • Geographic area with high prevalence (>10%) of penicillin-nonsusceptible S. pneumoniae

Children with these risk factors should receive high-dose amoxicillin-clavulanate (90 mg/kg/day of amoxicillin component) rather than standard-dose amoxicillin as first-line therapy. 1

Important Clinical Caveats

  • Previous respiratory infections alone do not constitute a specific risk factor unless they represent recurrent ABRS (≥4 episodes/year) warranting evaluation for underlying conditions. 1
  • The presence of purulent nasal discharge does not indicate bacterial infection, as nasal discharge commonly transitions from clear to purulent during uncomplicated viral URIs. 3, 4
  • Most children in day care experience 6-8 URIs per year, and chronic nasal congestion is typically due to sequential viral infections rather than ABRS or allergic rhinitis. 2
  • Imaging abnormalities alone are not sufficient for diagnosis, as 68% of symptomatic children with viral URI and 42% of healthy children have significant sinus abnormalities on imaging. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Frequent URIs and Chronic Nasal Congestion in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Viral Upper Respiratory Tract Infection Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosing Bacterial Sinusitis at 5 Days

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the next step for a pediatric patient with bacterial sinusitis who did not improve after 72 hours of amoxicillin treatment?
What is the best medication for pediatric rhinosinusitis?
What is the first line treatment for bacterial rhinosinusitis?
What is the treatment for an 8-year-old child with green nasal discharge and fever?
What is the most appropriate next step for a pediatric boy with fever, headache, severe periorbital (around the eye) pain and swelling, and purulent (containing pus) nasal discharge, who had a recent history of a clear runny nose and low-grade fever that resolved?
Is azithromycin (Zithromax) safe to use in patients with a history of seizures or epilepsy who are taking levetiracetam (Keppra)?
What is the recommended dosage of pregabalin (Lyrica) for an adult patient with generalized anxiety disorder and potentially impaired renal function?
What is the likely diagnosis for an adult patient with a history of autoimmune or rheumatological disorders, presenting with polyarthritis, anemia, elevated Lactate Dehydrogenase (LDH) levels, and a positive anti-centromere antibody test?
What are the recommended medications for treating type 2 diabetes?
What antibiotic should be used to treat a patient with a penicillin allergy who has tested positive for streptococcal (strep) infection?
What are the symptoms and treatment for a young to middle-aged adult with a history of diabetes, possibly type 1, presenting to the emergency room (ER) with suspected diabetic ketoacidosis (DKA)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.